Axxent Surface Controller
Payments companies reported to CMS as associated with Axxent Surface Controller. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Axxent Surface Controller, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Axxent Surface Controller
These are the largest totals companies reported as associated with Axxent Surface Controller. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Mark Traill | Wyoming, MI | Diagnostic Radiology | $10,949.74 |
| Colleen Madden | Muncie, IN | Diagnostic Radiology | $292.57 |
| Peter Eby | Philadelphia, PA | Diagnostic Radiology | $283.96 |
| Emily Fox Conant | Philadelphia, PA | Diagnostic Radiology | $283.62 |
| Markus Holzhauer | Williamsville, NY | Neuroradiology | $283.62 |
| Drew Davis | Greensboro, NC | Diagnostic Radiology | $179.67 |
| Walton Taylor | Dallas, TX | Surgery | $163.93 |
| Sean Raj | Dallas, TX | Diagnostic Radiology | $163.93 |
| Peter Beitsch | Dallas, TX | Surgical Oncology | $163.93 |
| Vitaly Blatnoy | Oviedo, FL | Dermatology | $15.42 |
Prescribed Axxent Surface Controller?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.